Market Cap 519.51M
Revenue (ttm) 174.43M
Net Income (ttm) -138.89M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -79.63%
Debt to Equity Ratio 0.00
Volume 834,600
Avg Vol 1,405,852
Day's Range N/A - N/A
Shares Out 382.00M
Stochastic %K 39%
Beta 1.29
Analysts Sell
Price Target $1.77

Company Profile

Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates in two segments, Proteomics and Genomics. Its proteomics and genomics include instruments, consumables, software, and services based upon technologies used in the identification of proteins, as well...

Industry: Medical Devices
Sector: Healthcare
Phone: 650 266 6000
Fax: 650 871 7152
Address:
2 Tower Place, Suite 2000, South San Francisco, United States
grnback
grnback Sep. 9 at 8:00 PM
$LAB No brainer.
0 · Reply
MGeronimo
MGeronimo Sep. 8 at 11:15 PM
$LAB Accumulating at 1.37
0 · Reply
Sensore
Sensore Sep. 8 at 7:57 PM
$LAB ..
0 · Reply
Sensore
Sensore Sep. 8 at 11:49 AM
$LAB ..
0 · Reply
AZOZ
AZOZ Sep. 8 at 11:14 AM
$VBIX $LAB insider's love it right now!
0 · Reply
TAgurus
TAgurus Sep. 6 at 6:38 PM
$LAB insider transactions: 8 buys, 0 sells.
0 · Reply
beckphan08
beckphan08 Sep. 4 at 12:57 AM
$LAB not impressed, now they are firing a bunch of American workers to move operations over seas. Yikes
0 · Reply
Glenniron
Glenniron Aug. 27 at 10:03 PM
0 · Reply
Stox_Tr
Stox_Tr Aug. 27 at 5:23 PM
$OPK $DDD $LAB following inside buying can be very profitable. Slow and steady
1 · Reply
Stox_Tr
Stox_Tr Aug. 27 at 5:00 PM
$LAB in at 1.26. Undervalued
1 · Reply
Latest News on LAB
Standard BioTools Reports Second Quarter 2025 Financial Results

Aug 11, 2025, 4:01 PM EDT - 4 weeks ago

Standard BioTools Reports Second Quarter 2025 Financial Results


Standard BioTools Reports First Quarter 2025 Financial Results

May 6, 2025, 4:01 PM EDT - 4 months ago

Standard BioTools Reports First Quarter 2025 Financial Results


Standard BioTools Inc. (LAB) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 9:44 PM EST - 6 months ago

Standard BioTools Inc. (LAB) Q4 2024 Earnings Call Transcript


Standard BioTools Appoints Alex Kim as Chief Financial Officer

Nov 7, 2024, 8:00 AM EST - 10 months ago

Standard BioTools Appoints Alex Kim as Chief Financial Officer


Standard BioTools Inc. (LAB) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 7:10 PM EDT - 11 months ago

Standard BioTools Inc. (LAB) Q3 2024 Earnings Call Transcript


Standard BioTools Reports Third Quarter 2024 Financial Results

Oct 30, 2024, 4:01 PM EDT - 11 months ago

Standard BioTools Reports Third Quarter 2024 Financial Results


Standard BioTools Inc. (LAB) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 8:34 PM EDT - 1 year ago

Standard BioTools Inc. (LAB) Q2 2024 Earnings Call Transcript


Standard BioTools Announces Senior Leadership Changes

Jul 31, 2024, 4:02 PM EDT - 1 year ago

Standard BioTools Announces Senior Leadership Changes


Standard BioTools Inc. (LAB) Q1 2024 Earnings Call Transcript

May 11, 2024, 12:45 PM EDT - 1 year ago

Standard BioTools Inc. (LAB) Q1 2024 Earnings Call Transcript


Standard BioTools Inc. (LAB) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 8:44 PM EST - 1 year ago

Standard BioTools Inc. (LAB) Q4 2023 Earnings Call Transcript


Standard BioTools Stockholders Approve Merger with SomaLogic

Jan 4, 2024, 10:23 PM EST - 1 year ago

Standard BioTools Stockholders Approve Merger with SomaLogic


grnback
grnback Sep. 9 at 8:00 PM
$LAB No brainer.
0 · Reply
MGeronimo
MGeronimo Sep. 8 at 11:15 PM
$LAB Accumulating at 1.37
0 · Reply
Sensore
Sensore Sep. 8 at 7:57 PM
$LAB ..
0 · Reply
Sensore
Sensore Sep. 8 at 11:49 AM
$LAB ..
0 · Reply
AZOZ
AZOZ Sep. 8 at 11:14 AM
$VBIX $LAB insider's love it right now!
0 · Reply
TAgurus
TAgurus Sep. 6 at 6:38 PM
$LAB insider transactions: 8 buys, 0 sells.
0 · Reply
beckphan08
beckphan08 Sep. 4 at 12:57 AM
$LAB not impressed, now they are firing a bunch of American workers to move operations over seas. Yikes
0 · Reply
Glenniron
Glenniron Aug. 27 at 10:03 PM
0 · Reply
Stox_Tr
Stox_Tr Aug. 27 at 5:23 PM
$OPK $DDD $LAB following inside buying can be very profitable. Slow and steady
1 · Reply
Stox_Tr
Stox_Tr Aug. 27 at 5:00 PM
$LAB in at 1.26. Undervalued
1 · Reply
jano500ab
jano500ab Aug. 27 at 1:59 PM
$LAB INSIDERS buying Company has lots $CASH on hand And low debt.
0 · Reply
MGeronimo
MGeronimo Aug. 27 at 3:51 AM
$LAB ON AT 1.28 pm 52k insider buying
0 · Reply
peepthestamp
peepthestamp Aug. 20 at 1:49 PM
Insider Buys (Strong Signals) • $MIZR – Clustered exec buys = strong insider conviction. • $NUGN – ~$1M insider buy in a penny stock = big weight, likely momentum. • $CCEL – CFO steady buys = confidence signal. • $LAB – Casdin Partners adding 358K+ shares = smart biotech money stacking. 👉 In short: MIZR = alignment, NUGN = size, CCEL = finance confidence, LAB = smart accumulation.
1 · Reply
MGeronimo
MGeronimo Aug. 18 at 5:37 PM
$LAB ADDING AT 1.26 on insider buying…….
1 · Reply
AlertsAndNews
AlertsAndNews Aug. 17 at 10:21 PM
$LAB Standard BioTools: Casdin Private Growth Equity Fund GP, LLC (Director) Buys 358,220 Shares at $1.24 Avg – Form 4 The securities are owned directly by Eli Casdin, reflecting an insider purchase totaling $444K
1 · Reply
GreenPond
GreenPond Aug. 17 at 8:48 PM
$LAB More insider purchase, + 358K shares Form 4: https://investors.standardbio.com/static-files/ab6cfd1a-105d-4d0d-83ce-eeffcc6d5f36
0 · Reply
d_risk
d_risk Aug. 17 at 5:35 AM
$LAB - Standard BioTools Inc. Common Stock - 10Q - Updated Risk Factors LAB flags new risks: divestitures or other deals could hit costs, revenues, and profitability, and delays in a key Transaction may undermine expected benefits. #Biotechnology #RevenueImpact #CostRisk #TransactionDelays #Divestitures 🟢 Added 🟠 Removed https://d-risk.ai/LAB/10-Q/2025-08-15
1 · Reply
MGeronimo
MGeronimo Aug. 16 at 1:50 AM
$LAB ADDING AT 1.21 on insider buying
0 · Reply
MGeronimo
MGeronimo Aug. 16 at 1:49 AM
$LAB 350k insider buys
0 · Reply
Estimize
Estimize Aug. 13 at 8:00 PM
Wall St is expecting -0.05 EPS for $LAB Q3 [Reporting 11/11 AMC] http://www.estimize.com/intro/lab?chart=historical&metric_name=eps&utm_con
0 · Reply
viveckpl
viveckpl Aug. 12 at 1:52 AM
$LAB down tomorrow
1 · Reply
mikesterz7
mikesterz7 Aug. 11 at 9:58 PM
$LAB 🚨 🚨 🚨 Standard Biotools reported second quarter EPS of $-0.050, $0.02 better than the analyst estimate of $-0.070. Revenue for the quarter came in at $21.76M versus the consensus estimate of $39.83M. Guidance Standard Biotools sees FY 2025 revenue of $165.000M-$175.000M versus the analyst consensus of $169.100M.
0 · Reply